Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 17%
Hold 50%
Sell 17%
Strong Sell 0%

Bulls say

Omega Healthcare Invts is a strong investment opportunity due to its well-diversified portfolio of healthcare real estate properties, strategic partnerships with third-party operators, and proactive portfolio management. The company has a solid earnings report and is projected to continue its growth with a 4.7% core earnings growth rate in 2028. While there are some potential risks, such as an unpredictable regulatory environment and potential impacts from tenant issues, there are also upside risks of favorable reimbursement changes and attractive acquisition opportunities. Overall, Omega Healthcare Invts is well-positioned for long-term success in the healthcare real estate market.

Bears say

Omega Healthcare Invts is a real estate investment trust that owns healthcare-related properties in the U.S., U.K. and Canada, with a focus on skilled nursing facilities. The negative outlook is driven by risks related to economic and regulatory trends, as well as uncertainties surrounding the company's tenants, particularly the PACS Group which is under federal investigation. Additionally, the company's limited ability to directly influence its tenants and its recent reduction in FFO estimates also contribute to the negative outlook.

OHI has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 17% recommend Buy, 50% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Hold based on their latest research and market trends.

According to 12 analysts, OHI has a Hold consensus rating as of Jul 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.